• 沒有找到結果。

心臟疾病患者的護理

N/A
N/A
Protected

Academic year: 2022

Share "心臟疾病患者的護理"

Copied!
53
0
0

加載中.... (立即查看全文)

全文

(1)

心臟疾病患者的護理

邱愛富

(2)

心臟血管系統的解剖 生理功能

邱愛富

(3)

一、心臟的構造與功能 :

• heart size: 拳頭, 250-350 gm

• heart location: 2/3 胸骨中線左側;

• Base:2nd 肋骨; Apex:5th 肋間 & L’t 鎖骨 中線

• heart function:

– deliver O2 and other essential substitute to tissu e of body

– remove CO2 & 代謝產物

(4)

心臟壁層 :

• 心包膜 (pericardium)

– 1) 外層 ( 壁心包膜 ) :纖維性—防止 heart 過度擴張

、有保護、固定

– 2) 內層 ( 臟心包膜 ) :漿膜性—

– 兩層間為心包膜腔,含 15-50 cc 心包膜液,可防止收 縮時的磨擦

• 心外膜 (epicardium);

• 心肌 (myocardium)-- 不隨意肌,具橫紋及分枝的 纖維,有收縮作用

• 心內膜 (endocardium)

(5)

Coronary vasculature

• Right coronary artery (RCA )、

• Left main--Left anterior descending artery (LAD) 、 Left circumflex (LCX)

• Ascending aorta (75% at diastolic)

 RCA (supply RA, RV, post LV, 90% AV node)

 Left main LAD (supply Ant. LV, apex) 、 LCX (supply lateral LV, LA)

(6)

The Cardiac Cycle

• Blood Circulation Circuits

– Pulmonary Circuit – lungs

– Systemic Circuit - whole body

• Cardiac Cycle

– Systole – contraction – Diastole – relaxation

– Atria relax when Ventricles contract and vice versa

(7)

Steps in a contraction

• When atria fill pressure opens AV valves

• Atria contraction fills ventricles completely

• Ventricles begin to contract and AV valves snap shut (LUB)

• Increased contraction (inc. pressure) forces semilunar valves open

• Blood flows into vessels leading away. Pressure increa ses and forces SL valves shut (DUB)

• Process begins again

(8)

Cardiac Output

• 心輸出量 (CO) = 心搏出量 (SV) x 心跳速率 (HR)

• 心搏出量 (Stroke volume) :每一次心室收縮時所 排出的血量,同時受到前負荷,後負荷及心臟收縮 力的影響

• 心輸出量的決定因素

– 前負荷 (preload): 心室舒張末期 , 心肌所承受的張力 – 後負荷 (Afterload): 心室收縮時所遭遇的阻力

– 心臟收縮力 (Contractility)

– 心跳速率與節律 (heart rate & rhythm)

(9)

前負荷 (Preload)

Frank-Starling 定律 : 舒張容積 (= 前負荷 )  心室收 縮強度  輸出容積

• (myocardium fiber length↑ preload ↑ LVEDV↑S V↑)

• 臨床上:以進入心室的血量多寡為代表(一般用 CVP 及 PAW P 估計)

(10)

Contractility 收縮力

• Vpk for the left ventricle is around 1.1 – 1.5 m/s in healthy patients.

• In patients with cardiac failure or low contr actility/inotropy this figure might well be on ly 0.6 or 0.7 m/s or even less.

• For the right ventricle the figure would be 0 .7 to 1.2 in healthy patients.

(11)

後負荷 (Afterload)

• Ohm’s law:

R =  P/Q

– SVR = (MABP – CVP)/CO (systemic vascul ar resistance)

– PVR = (MPAP – LAP)/CO (pulmonary vas cular resistance)

• 臨床評估 : SVR and PVR

A high BP meansthat the ventricle is pu

shing uphill High viscosity and vasoconstriction mean

(12)

Cardiac Output

• The amount of blood ejected by the left ventricl e in one minute

• CO = HR X SV

• Heart rate is 75 beats per min

• Stroke volume is 70 ml per beat

• Blood volume?? do calculation

• CO=SVxHR = 60-130 cc/beat X 75 beat/min = 4- 8 L/min

(13)

Cardiac function index

• Ejection Fraction 心射出分率

– Is % of blood ejected with every beat

– =SV/LVEDV=2/3=60-75% (Normal>50%) – Reflect LV performance

• Cardiac index(CI) 心臟指數

• Cardiac reserve 心臟儲備量

(14)

Cardiac index(CI) 心臟指數

• Is CO corrected for differences in body size

• =CO/body surface area= 2.5-4 L/min/m2

www.learnhemodynamics.com/hemo/contract.htm

(15)

Cardiac reserve 心臟儲備量

• Cardiac reserve= ability to respond to the de mand for increased CO (eg. Exercise,stress)

• Normal: 300-400%

(16)

Conduction System

Sinoatrial node (SA node) - RA, "fastest" autorhythmic ti ssue (pacemaker, 60-100 bpm)

• Atrioventricular node (AV node) - last part of atria to de polarize signal hesitates then proceeds to ventricles (40-6 0 bpm)

• AV bundle (bundle of His) - connects atria to ventricles

• Rt and Lt bundle branches - send signal to apex of heart

• Purkinje fibers - action potential sent throughout ventricl e tissue (20-40 bpm)

(17)

心臟電氣生理特性

• 自律性

(Automaticity)— 心肌自動去極化

的能力,規則自動的激發衝動 (Impulses)

的能力,主要由 SA node 擔任 Pacemaker 激搏點

• 興奮性

(Excitability)-- 心肌對於刺激產生

去極化的能力 ( 被衝動激發產生興奮 )

• 傳導性

(Conductivity)-- 心肌經由細胞膜 傳送刺激衝動的能力

• 不反應期 (Refractoriness)-- 心肌仍然處 於前一刺激之收縮,無法對於新刺激反 應的時期

(18)

Neurologic Control of the Heart

• Autonomic nervous system ( 自主神經的控 制 )

– Sympathic  NE β1 ↑HR, contractil ity↑CO,BP

– Parasympathic ACH ↓HR, contractili ty

(19)

壓力接受器 (Baroreceptor) 與化 學接受 (Chemoreceptor)

• 壓力接受器 (Baroreceptor :位於頸動脈竇、主 動脈竇、心房

– BP↑baroreceptortrasfer massage to vasom otor center at medula stimulate parasymp.

inhibit symp. ↓HR, contractility

• 化學接受器 (Chemoreceptor) :位於頸動脈體、

主動脈體附近

– PO2, PH, PCO2↓ stimulate chemreceptor va somotor center↑cardiac activity ↑PO2

(20)

 心臟血管疾病的評估及診 斷檢查 

• Nursing assessment: history, Golden

• Physical examination

• Diagnostic tests

– Laboratory

– Hemodynamic monitoring – Non-invasive tests

• ECG, Treadmill, Echo, Nuclear cardiology, CT, MRI

– Invasive tests

• Cardiac catheterization, Coronary angiography, electrophysiol ogic study (EPS), endomyocardial biopsy(EMB), TEE, IVUS

(21)

Nursing assessment

• Main complaint:

– chest pain, dyspnea, fatigue, edema, palpitation, syncope

• History of present illness:

– onset, signs & symptoms

• Past medical history:

– previous illness, injuries, surgery, medication

• Risk factors: family history, smoking, activity, diet, pe rsonality

• Golden’s 11 functional health patterns

(22)

Chest Pain Assessment

Assessment Angina Pericarditis

Provocation/

Palliation

Exercise/rest Deep breath, 平躺 / 前傾、坐起

Quality/

Quantity

壓迫感、沉重、消 化不良感

尖銳如刀割

Region/Radiation 胸骨、頸、左手臂

、肩

Severity 中度 中至重度

Time/onset, <10 min Several hrs to days

(23)

Dyspnea

• SOB (short of breath) 呼吸短促

• DOE (Dyspnea on exercise/exertion) 運動時呼吸 困難 , 最常見於 walk, crimb stair

• Orthopnea 端坐呼吸 , 無法平躺,半坐臥緩解

• PND (paroxysmal nocturnal dyspnea) 夜間陣發性 呼吸困難 ,

(24)

Physical examination- Inspection

skin: central cyanosis (lip, mouth, conjundi val)poor arterial circulation

• peripheral cyanosis(lip, ear, nail)peripher al vasoconstriction

• Eyes: arcus senitis 老人弓 , Xanthelasma 黃斑瘤  atherosclerosis

(25)

Physical examination- Inspection

• Fingers clubbing 杵狀指 PO2↓or lun g cancer

• Capillary refill (circulation): press nail to br anches,color return<2 sec

(26)

Physical examination- Inspection

• Skin tugor (elastrictry): 捏起 skin, return ti me>30 secdehydration, BW↓

• Edema: press 5 sec, remove(+<1/4”, ++ 1/4

”-1/2”, +++1/2”-1”)

(27)

Physical exam-Vital sign

• BP:

– bilateral BP: L’t & R’t SBP difference>15 mmHg↓aorta blood flow in lower arm – Pulse pressure:SBP-DBP=30~50,

– Orthostatic BP: lying-standing>20dehydration, poor HTN, aorta disease

(28)

Physical exam-Vital sign

• pulse: rate, rhythm, amplitude, bilateral

– pulsus paradoxus( 奇脈 ): pulse change with 呼吸 , 吸  pulse weaken, BP↓

– pulsus alternanus( 交替脈 ):pulse change with HR, – pulsation:0=none, +=weak, ++=normal, +++=strong

(29)

Physical examination

• Carotid artery: thrill, bruit(vessel murmur): arteria l narrowing

• Jugular vein pressure (JVP)<2 cm

• Hepatojugular reflux

(30)

Physical examination

• Palpation & Auscultation of precordium

– Areas: aortic, pulmonary, tricuspid, mitral, apex , PMI

– S1, S2, Abnormal heart sounds: murmur, click, friction rub

(31)

Diagnostic studies

• Laboratory :

– CBC, e-, Cholesterol, HDL, LDL, TG, cardiac enzymes ( CPK-MB, LDH, troponinT & I, myoglobin)

PT(prothrombin time), (International normalized ratio;

INR) 、 PTT, BUN, Cre, glucose

• Hemodynamic monitoring

– CVP=4~12 cmH2O; reflect RA pressure – Swan-Ganz: PAWP

(32)

EKG

(33)

12 lead EKG

• 雙極肢體導程 ( 縱切面 ): I, II, III

• 單極肢體導程 ( 縱切面 ):aVR, aVL, aVF

• 胸導程 ( 橫切面 ): V1, V2, V3, V4, V5, V6

(34)

Normal EKG

(35)

Holter Monitoring

• can record heart rate and rhythm when

patients feel chest pain or symptoms of an arrhythmia over a 24-hour period

• Ambulatory ECG; Dynamic ECG

• Developed in 1960s

(36)

Exercise Stress Tests (Treadmill

; 運動心電圖 )

• Dx :CAD, functional capacity Target HR=85%*max HR

Positive: ST depression>1mm

• Contraindications:

Unstable angina with recent chest pain Critical aortic stenosis

Severe hypertrophic obstructive cardiomyopathy Untreated life-threatening cardiac arrhythmias Uncompensated congestive heart failure

Advanced AV block

Acute myocarditis or pericarditis Uncontrolled hypertension

(37)

Echocardiography 超音波

• uses sound waves to produce an image of the heart an d to see how it is functioning.

• Transducer high frequency, short wave return

示波鏡、描繪圖影像

• show the size, shape, and movement of the heart mus cle, valves disease,blood flow, arteries.

• Types

– Motion-mode( 收縮、活動 ),

– 2 Dimensional-echo( 縱、橫向結構 ), – Doppler( 血流方向、流速 )

(38)

Transesophageal Echocardiogr aphy (TEE)

• The test is like standard echocardiography except that the pictures of the heart come from inside the esophagus rather than through the chest wall.

• NPO 6-8 hoursspraying throat with an

anesthetica tube (probe) put down the throat

• Gag reflex return,then eating

(39)

Intravascular Ultrasound (IVUS)

• is a combination of echocardiography and cardiac catheterization.

• uses sound waves, which are sent through a cathet er to artery and heart, to produce an image of the c oronary arteries and to see their condition.

• is rarely done alone or as a strictly diagnostic proc edure. It is usually done with a transcatheter interv ention like angioplasty.

(40)

Chest X ray

• Most commonly performed imaging test for CV system

• For evaluation of cardiac chamber size and great vessels

Chest X ray with enlarged heart size

(41)

Nuclear cardiology ( 心臟核子醫 學檢查 )

• Ejection fraction + wall motion

– Evaluation of cardiac performance and regional wall m otion

• Left ventricular diastolic phase index (MUGA)

Useful for evaluation of diastolic function Patients with atrial fibrillation

(42)

Nuclear cardiology

Tl-201 Single photon emission computed to mography (SPECT)

– Myocardial perfusion imaging – TET Tl-201, Persantin Tl-201

Positron emission tomography (PET)

– Myocardial blood flow and myocardial viability

(43)

Nuclear Cardiology

• Tc99 鎝同位素 (hot spot) :與壞死心肌之 Ca

++

結合 聚集於受損或梗塞之心肌部位

凸顯梗塞之心肌部位

 MI 4 hours 可發現, 24-72hrs 最靈敏

• Thallium 201 myocardial imaging 鉈 (cold sp ot): 測心肌灌注情形

– 聚集於心肌供血處,灌注好分佈均勻,缺 血處無法進入空白冷點 (cold spot)

(44)

Computed tomography (CT scan)

• Cardiac dimensions, calcifications and function – Ischemic heart disease, LV aneurysm, etc.

Pericardial disease

– Pericardial effusion, constrictive pericarditis, pe ricardial cyst

Paracardiac, pericardial and cardiac masses

Congenital heart disease

Disease of the thoracic aorta

– Aortic dissection, aortic aneurysm

Pulmonary embolism

(45)

Magnetic Resonance Imaging (MRI)

• Provide a 2-D view of the heart, including the chambers and valves, without having to inject a dye or insert a catheter.

• Interfere with pacemaker function

• Can’t use with prosthetic metallic devices (valves, prosthetic joints, pacemaker etc.

(46)

Invasive tests

Cardiac catheterization

– Coronary angiography (CAG)

• Electrophyiologic study (EPS)

• Endomyocardial biopsy (EMB)

(47)

心導管術的功能有哪些?

在檢查方面可以達到顯影評估心臟功能、

血流的情況或是血管阻塞的情形、記錄心 臟氧氣變化、測量心臟電位、測量心臟血 管各部位的壓力等。

在治療方面可以利用氣球擴張術或置入支 架撐開阻塞的血管段、將心律不整的原因 給予電燒灼,以及放置心律調整器等。

(48)

心導管檢查前需注意之事項

• 由醫師解釋心導管檢查的利弊,並簽寫同 意書。

• 禁食 4-6 小時。

• 檢查部位(穿刺部位)毛髮剔除。

• 檢查四肢末梢動脈循環及做上記號。

• 須換上手術衣,並取下假牙、義眼、眼鏡

、及所有飾物等。

• 檢查前先排空膀胱。

(49)

施行心導管之禁忌症

絕對禁忌

病患拒絕

設備或儀器不足

相對禁忌

控制不良之心臟衰竭 , 高血壓 , 心律不整 一個月以內之腦中風

發燒 / 感染 電解質不平衡 急性消化道出血 懷孕

易出血之體質或情形 無法合作之病人

腎衰竭

(50)

Cardiac catheterization

• post-cath :

– vital sign: q15min *4 → q30 min *2 (or 4) → q1h – 股動脈 :bed rest 6-8 hours, compress 4-6 hrs

– 橈動脈 : bed rest 1-2 hours, compress 2 hrs – check wound: bleeding ? infection ?

– check P+P (pulsation&perfusion) ?

• complications : bleeding, hemotoma, dye allergy , arrhythmia, thrombus

(51)

EPS (Electrophysiologic study)

• understand arrhythmia mechanism (eg. Add itional pathway)

• effects of drugs and ablation

• decide the need of pacemaker

(52)

Endomyocardial Biopsy(EMB)

Grade Finding Rejection Severity

0 No infiltrates None

1A Focal (perivascular of interstisial infiltrates without necr

osis Mild

1B Diffuse but not sparse infiltrate without necrosis Mild 2 One focus only with aggressive infiltrate and/or myocyte

damage Focal Moderate

3A Multifoca addressive infiltrates and/or myocyte damage Moderate

3B Diffuse inflammatory infiltrates with necrosis Borderline severe 4D Diffuse aggressive polymorphous infiltrate with edema, Severe

• International Society for Heart & Lung Transplantation End omyocardial Biopsy Grading Scheme

(53)

Review

• Anatomy and physiology of the heart

• Physical examination of cardiovascular syst em

• Nursing assessment

• Non-invasive tests: Lab., chest X-ray, EKG, echo, Nuclear cardiology, CT, MRI

• Invasive tests: Cath, EPS, EMB, TEE, IVU S

參考文獻

相關文件

黃色 51-144

Depending on the specified transfer protocol and data format, this action may return the InstanceID of an AVTransport service that the Control Point can use to control the flow of

3.CKD Stage 5 病人照護目標,應進行慢性腎臟病之醫病共同決 策(Shared Decision Making,

而考量到 Covid-19 重症病患的需求,醫院的重症病床數量格外重要。根據統 計,在 OECD 國家間,每十萬人擁有之重症病床數量差距可達 10 倍(如下圖)。. 歐盟疾病管制局 (European

4 SF12207 黃文豊 一項隨機、雙盲、多中心試驗,比較 Denosumab 與 Zoledronic Acid (Zometa®)治療新診斷出多發性骨髓瘤

取材 Pediatric Advanced Life Support 1997,

減少身體脂肪、降低患上癌症、心血管疾病和糖尿病的風險、促

根據內政部統計,97 年底領有身心障礙手冊者達 104 萬人,領有手冊之身 心障礙人口占總人口比率 4.5%。其中,慢性精神疾患者(以下簡稱精障者)在所 有身心障礙者